MDLive AI Market Strategy Report - Online Doctors

Answer Capsule

MDLive appears in 6.0% of AI observations across the Online Doctors category but earns valid recommendations in only 0.8% of them. The benchmark assigns MDLive a modeled monthly AI Authority Value of $22,308, the second lowest among ten tracked brands. The brand is present but rarely advanced as a top choice, with a net sentiment score of 0.16 indicating predominantly neutral framing. The clearest opportunity lies in converting existing visibility into recommendation power, particularly in the decision-stage pricing cluster where MDLive captures its highest relative value.

Who This Report Is For

This report is for MDLive marketing, brand, and strategy leaders evaluating the brand's current position in AI-generated patient shortlists and planning the next phase of AI visibility investment.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: MDLive
• Category / market studied: Online Doctors
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, Google AI Overviews
• Public high-intent clusters: 3 (Consideration, Evaluation, Decision)
• AI observations analyzed: 829
• Competitors tracked: 10

Executive Summary

MDLive holds a modest presence in AI-generated responses across the Online Doctors category, appearing in 50 of 829 total observations for a raw mention presence rate of 6.0%. The brand earns valid recommendations in only 7 of those observations, a valid recommendation coverage rate of 0.8%. This gap between presence and recommendation power is the defining characteristic of MDLive's current AI visibility profile.

The benchmark assigns MDLive a modeled monthly AI Authority Value of $22,308, placing it ninth among the ten tracked brands. Only HealthTap ($8,053) ranks lower. MDLive's AI Authority Value is composed of $12,949 in AI Recommendation Value and $9,359 in AI Visibility Assist Value, meaning nearly half of its value derives from neutral visibility rather than active recommendation credit.

MDLive's net sentiment score of 0.16 is the second lowest in the category. When the brand is mentioned, the framing is predominantly neutral. The brand has 42 neutral mentions, 8 positive mentions, and zero negative mentions across all observations. This neutral-heavy profile limits the brand's ability to convert presence into recommendation power.

The strongest cluster for MDLive is the decision-stage Telehealth Pricing, Cost and Plans cluster, where it captures $15,869 in AI Authority Value. This represents 71% of MDLive's total value, suggesting that pricing-related queries are where the brand has the most relative traction. Even in this cluster, however, MDLive's valid recommendation coverage is just 0.97%.

Google AI Mode is MDLive's strongest platform, contributing $20,482 in AI Authority Value, or 92% of the brand's total. On every other platform, MDLive's presence is minimal to negligible. This platform concentration is both a structural risk and a signal worth investigating.

What MDLive Is Winning

MDLive's clearest win is its presence in the decision-stage pricing cluster. In the Telehealth Pricing, Cost and Plans cluster, MDLive captures $15,869 in AI Authority Value, which is 71% of its total across all three clusters. When patients search for pricing and cost information, MDLive is more likely to appear in AI responses than in other query types.

On Google AI Mode, MDLive achieves its strongest platform performance at $20,482 in AI Authority Value. This single platform accounts for 92% of MDLive's total modeled value, indicating consistent presence where Google's AI surfaces pricing and comparison content.

MDLive has zero negative mentions across all 829 observations. The brand is predominantly framed neutrally, but it avoids the cautionary or negative framing that can suppress brand trust in AI-generated patient shortlists.

Where MDLive Has the Clearest AI Visibility Gaps

MDLive's most significant gap is the conversion of presence into recommendations. The brand appears in 50 observations but earns valid recommendations in only 7. Its valid recommendation coverage of 0.8% is among the lowest in the category. By comparison, PlushCare achieves 18.6% and Sesame achieves 13.2%. MDLive is present at the surface level but is not being advanced at the moment patient decisions are made.

The brand has near-zero presence on several key platforms. On ChatGPT, MDLive appears in only 2 of 84 observations. On Gemini, it appears in 5 of 175 observations with zero positive mentions. On Perplexity, it appears in 2 of 25 observations. This platform-level absence means MDLive is invisible to patients using these tools for telehealth discovery.

MDLive's net sentiment score of 0.16 is the second lowest in the category. Only LiveHealth Online (0.08) scores lower. The brand carries 42 neutral mentions compared to 8 positive mentions, meaning 84% of its mentions carry no positive framing. Neutral mentions create recognition but do not build the trust signals that drive patient selection.

In the consideration-stage cluster covering Best Telehealth Platforms and Top Virtual Care Services, MDLive captures only $3,015 in AI Authority Value with a valid recommendation coverage of 0.66%. This is the cluster where most patient discovery begins, and MDLive is functionally absent from the shortlist-forming stage.

Biggest Opportunity

MDLive's single biggest opportunity is to convert its existing neutral visibility into positive recommendation power by strengthening the public evidence layer that AI systems use to evaluate and advance brands. The brand appears often enough to be recognized but not often enough with the positive framing, comparison content, and citation architecture that drives recommendation credit. Building a stronger source footprint with structured official content, patient reviews, pricing pages, and third-party comparison coverage would give AI systems more material to synthesize into positive, recommendation-stage mentions.

Prompt Evidence

Google AI Mode / Decision (Telehealth Pricing, Cost and Plans) Prompt: "What are the costs for online doctor visits?" Result: MDLive appeared in the response but was not recommended in the top three positions.

Gemini / Consideration (Best Telehealth Platforms) Prompt: "What are the best telehealth platforms?" Result: MDLive was not mentioned in the AI response.

ChatGPT / Evaluation (Telehealth Platform Comparisons) Prompt: "Compare telehealth platforms for primary care" Result: MDLive appeared in the response with neutral framing and no recommendation credit.

Google AI Overviews / Consideration (Top Virtual Care Services) Prompt: "Best online doctor services" Result: MDLive appeared in the response with a positive mention but was not ranked in the top three.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map MDLive's current AI recommendation footprint across all six platforms and identify the specific prompts, clusters, and competitor displacement patterns driving the visibility-to-recommendation gap.

Phase 2: Recommendation Readiness Plan Identify the source-layer gaps that prevent MDLive from converting mentions into recommendations, including missing comparison content, weak patient review signals, and incomplete pricing information.

Phase 3: Owned Answer Layer Buildout Develop structured content for MDLive's official website that addresses the high-intent prompts where the brand is currently absent or neutrally framed.

Phase 4: Citation / Authority Layer Development Build third-party citation coverage through comparison articles, review platforms, and directory listings that AI systems can retrieve and synthesize into positive recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track MDLive's recommendation-stage visibility monthly to measure progress, identify new gaps, and adjust strategy as AI platforms evolve.

Why This Matters

Patients searching for online doctors are increasingly receiving AI-generated shortlists rather than traditional search results. These AI responses act as de facto recommendation engines, compressing the consideration set to three to five brands per query. A brand that appears in a response but is not recommended in the top three is effectively invisible to the patient making a decision.

MDLive's current position shows presence without recommendation power. The brand is recognized by AI systems but is not being advanced as a top choice. In a market where two brands capture the majority of AI recommendation value, the gap between visibility and recommendation is where patient decisions are lost. The next move for MDLive is to build the source-layer evidence that converts neutral mentions into positive recommendations at the moment the shortlist is formed.

Core Metrics

• Mentions: 50
• Valid recommendations: 7
• Top 3 recommendation count: 3
• Rank 1 recommendation count: 1
• Average recommended rank: 3.43
• Positive mentions: 8
• Neutral mentions: 42
• Negative mentions: 0
• Raw mention presence rate: 6.0%
• Valid recommendation coverage: 0.8%
• Top 3 recommendation rate: 0.4%
• Rank 1 recommendation rate: 0.1%
• Strongest cluster by recommendation behavior: Telehealth Pricing, Cost and Plans (Decision)
• Strongest platform by recommendation behavior: Google AI Mode

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

MDLive Sentiment Score = (8 x 1 + 42 x 0 + 0 x -1) / 50 = 8 / 50 = 0.16

This score matters because unclassified mention counts are misleading. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not the same thing. Counting all mentions as wins produces bad measurement and worse strategy. Classified sentiment is required before interpreting AI visibility in any commercially meaningful way. MDLive's score of 0.16 confirms that the brand's mentions are predominantly neutral, which limits its ability to drive patient trust and selection in AI-generated shortlists.

Sentiment by Platform

A note on the Gemini row: the original dataset readout used "No public presence in this packet" for this platform, but Gemini carries 5 mentions with a 0.00 sentiment score. The readout has been revised to "Present as context, not recommendation" to accurately reflect the observation count. This is a minor taxonomy correction and does not affect any other metric in this report.

Methodology

1. Report orientation: This is a benchmark-based AI Company Market Strategy Report analyzing MDLive's visibility and recommendation power in the Online Doctors category. It is not a client implementation case study and does not reflect a CiteWorks Studio engagement.
2. Reporting window: June 2026, snapshot date June 16, 2026.
3. Platforms tracked: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, Google AI Overviews.
4. Observation count: 829 total observations across three public high-intent clusters.
5. Competitor universe: Amwell, Doctor on Demand, HealthTap, K Health, Lemonaid Health, LiveHealth Online, MDLive, PlushCare, Sesame, Teladoc. This universe may not include every brand active in the category.
6. Public clusters used: Consideration (Best Telehealth Platforms and Top Virtual Care Services), Evaluation (Telehealth Platform Comparisons and Alternatives), Decision (Telehealth Pricing, Cost and Plans).
7. Stage 0 role: The metrics aggregation file provided the structured benchmark data used in this report. Raw AI observations were used to support prompt-level examples but were not exhaustively analyzed for this company-specific readout.
8. Definition of a mention: A mention means the company name appeared in an AI-generated response, regardless of sentiment, rank, or recommendation quality.
9. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality mention that earns recommendation credit based on framing and position. Visibility is not the same as recommendation credit, and this report tracks both separately.
10. Modeled value note: AI Authority Value, AI Recommendation Value, and AI Visibility Assist Value are modeled benchmark estimates. They are not revenue, pipeline, or booked demand figures. They are category-relative signals useful for comparing brand positioning across the competitive set.
11. Cluster scope limitation: The public benchmark covers three of ten total prompt clusters available in the full LLM Authority Index dataset. This report reflects only the public cluster set and may not capture the full scope of MDLive's AI visibility or competitive position across all query types.
12. Point-in-time limitation: AI platform outputs change continuously. This report reflects a June 2026 snapshot and should be interpreted as a benchmark reading, not a permanent characterization of MDLive's AI visibility.

See How AI Is Recommending Your Brand

The benchmark shows which brands are winning AI recommendations in the Online Doctors category and where the recommendation value is concentrated. The deeper question is where your brand stands across all platforms and prompt types, and what changes to the source layer, content architecture, and citation footprint would move the needle. CiteWorks Studio maps where a brand appears, where competitors are recommended instead, which prompts carry the most commercial risk, and what needs to change to improve recommendation-stage visibility in AI-generated patient shortlists.